Graham J. Riley

5.6k citations

70 papers · 4.1k indexed · h-index 31

Cellular and Molecular Neuroscience top 0.5%
Molecular Biology top 5%
Organic Chemistry top 2%
Pharmacology top 1%
Cognitive Neuroscience top 5%

Co-authors: Steven M. Bromidge Derek N. Middlemiss Tania O. Stean Ian T. Forbes Vicky Holland David R. Thomas Jim J. Hagan Martyn Wood
Topics: Receptor Mechanisms and Signaling (35 papers)Neurotransmitter Receptor Influence on Behavior (20 papers)Pharmacological Receptor Mechanisms and Effects (10 papers)
Cited by: Cellular and Molecular Neuroscience Endocrine and Autonomic Systems Pharmacology
Journals: The Lancet Journal of Medicinal Chemistry Journal of Neurochemistry
Partner nations: United Kingdom United States Italy

In The Last Decade

Graham J. Riley

70 papers receiving 3.9k citations

Peers

Countries citing papers authored by Graham J. Riley

Since Specialization

Citations

This map shows the geographic impact of Graham J. Riley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Graham J. Riley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Graham J. Riley more than expected).

Fields of papers citing papers by Graham J. Riley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Graham J. Riley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Graham J. Riley. The network helps show where Graham J. Riley may publish in the future.

Co-authorship network of co-authors of Graham J. Riley

This figure shows the co-authorship network connecting the top 25 collaborators of Graham J. Riley. A scholar is included among the top collaborators of Graham J. Riley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Graham J. Riley. Graham J. Riley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Pharmacological Profile of Antipsychotics at Monoamine Receptors: Atypicality Beyond 5-HT2A Receptor Blockade 2006 ·CNS & Neurological Disorders - Drug Targets ·Martyn Wood,Claire M. Scott,(unknown),(unknown),Nisha Patel,(unknown),Angela Worby,Laurie Gordon,(unknown),Graham J. Riley,Ceri H. Davies,Andrew D. Gribble,Declan N.C. Jones	30
2	The design of 8,8-Dimethyl[1,6]naphthyridines as potential anticonvulsant agents 2003 ·Bioorganic & Medicinal Chemistry Letters ·Nigel Austin,Michael S. Hadley,John D. Harling,Frank P. Harrington,Gregor J. Macdonald,Darren J. Mitchell,Graham J. Riley,Tania O. Stean,Geoffrey Stemp,Sharon C. Stratton,Mervyn Thompson,Neil Upton	22
3	SB‐656104‐A, a novel selective 5‐HT₇ receptor antagonist, modulates REM sleep in rats 2003 ·British Journal of Pharmacology ·David R. Thomas,Sergio Melotto,(unknown),Andrew D. Gribble,Philip D. Jeffrey,Alexander J. Stevens,Nigel Deeks,Peter Eddershaw,(unknown),Graham J. Riley,Tania O. Stean,Claire M. Scott,Matthew Hill,Derek N. Middlemiss,Jim J. Hagan,Gary Price,Ian T. Forbes	101
4	Bicyclic piperazinylbenzenesulphonamides are potent and selective 5-HT6 receptor antagonists 2002 ·Bioorganic & Medicinal Chemistry Letters ·Steven M. Bromidge,Stephen E. Clarke,Frank D. King,Peter J. Lovell,Helen Newman,Graham J. Riley,Carol Routledge,Halina T. Serafinowska,Douglas R. Smith,David R. Thomas	12
5	Pharmacological profile of SB-357134: A potent, selective, brain penetrant, and orally active 5-HT6 receptor antagonist 2002 ·Pharmacology Biochemistry and Behavior ·Tania O. Stean,Warren D. Hirst,David R. Thomas,Gary Price,Derek C. Rogers,Graham J. Riley,Steven M. Bromidge,Halina T. Serafinowska,Douglas R. Smith,(unknown),Nigel Deeks,Mark Duxon,Neil Upton	53
6	SB-243213; a selective 5-HT2C receptor inverse agonist with improved anxiolytic profile: lack of tolerance and withdrawal anxiety 2001 ·Neuropharmacology ·Martyn Wood,Charlie Reavill,Brenda Trail,Alex Wilson,Tania O. Stean,G.A. Kennett,Sean Lightowler,T.P. Blackburn,David W. Thomas,Tracey Gager,Graham J. Riley,Vicky Holland,Steven M. Bromidge,Ian T. Forbes,(unknown)	78
7	Design and synthesis of novel 2,3-dihydro-1H-isoindoles with high affinity and selectivity for the dopamine D3 receptor 2001 ·Bioorganic & Medicinal Chemistry Letters ·Nigel Austin,Kim Y. Avenell,Izzy Boyfield,Clive L. Branch,Michael S. Hadley,Philip D. Jeffrey,Christopher N. Johnson,Gregor J. Macdonald,(unknown),Graham J. Riley,Alexander B. Smith,Geoffrey Stemp,Kevin M. Thewlis,Antonio Vong,Martyn Wood	13
8	Characterization of SB‐269970‐A, a selective 5‐HT₇ receptor antagonist 2000 ·British Journal of Pharmacology ·Jim J. Hagan,Gary Price,Philip D. Jeffrey,Nigel Deeks,Tania O. Stean,D.C Piper,Martin Smith,Neil Upton,Andrew D. Medhurst,Derek N. Middlemiss,Graham J. Riley,Peter J. Lovell,Steven M. Bromidge,David R. Thomas	254
9	Novel 2,3,4,5-tetrahydro-1H-3-benzazepines with high affinity and selectivity for the dopamine D3 receptor 2000 ·Bioorganic & Medicinal Chemistry Letters ·Nigel Austin,Kim Y. Avenell,Izzy Boyfield,Clive L. Branch,Michael S. Hadley,Philip D. Jeffrey,Christopher N. Johnson,Gregor J. Macdonald,David J. Nash,Graham J. Riley,Alexander B. Smith,Geoffrey Stemp,Kevin M. Thewlis,Antonio Vong,Martyn Wood	15
10	Evidence for antagonist activity of the dopamine D3 receptor partial agonist, BP 897, at human dopamine D3 receptor 2000 ·European Journal of Pharmacology ·Martyn Wood,Izzy Boyfield,(unknown),Frances Jewitt,Kim Y. Avenell,Graham J. Riley	58
11	1-[2-[(Heteroaryloxy)heteroaryl]carbamoyl]indolines: novel and selective 5-HT2C receptor inverse agonists with potential as antidepressant/Anxiolytic agents 2000 ·Bioorganic & Medicinal Chemistry Letters ·Steven M. Bromidge,Steven Dabbs,Susannah Davies,D. Malcolm Duckworth,Ian T. Forbes,Graham E. Jones,(unknown),Frank D. King,(unknown),Thomas P. Blackburn,Vicky Holland,G.A. Kennett,Sean Lightowler,Derek N. Middlemiss,Graham J. Riley,Brenda Trail,Martyn Wood	16
12	Characterization of SB‐271046: A potent, selective and orally active 5‐HT₆ receptor antagonist 2000 ·British Journal of Pharmacology ·Carol Routledge,Steven M. Bromidge,Stephen F. Moss,Gary Price,Warren D. Hirst,Helen Newman,Graham J. Riley,Tracey Gager,Tania O. Stean,Neil Upton,Stephen E. Clarke,Anthony M. Brown,Derek N. Middlemiss	119
13	Heterocyclic analogues of 2-aminotetralins with high affinity and selectivity for the dopamine D3 receptor 1999 ·Bioorganic & Medicinal Chemistry Letters ·Kim Y. Avenell,Izzy Boyfield,Michael S. Hadley,Christopher N. Johnson,David J. Nash,Graham J. Riley,Geoffrey Stemp	14
14	Functional characterisation of the human cloned 5‐HT₇ receptor (long form); antagonist profile of SB‐258719 1998 ·British Journal of Pharmacology ·David R. Thomas,(unknown),(unknown),Derek N. Middlemiss,Graham J. Riley,Jim J. Hagan,Israel Gloger,Catherine Ellis,Ian T. Forbes,Anthony M. Brown	103
15	Fused aminotetralins: novel antagonists with high selectivity for the dopamine D3 receptor 1998 ·Bioorganic & Medicinal Chemistry Letters ·Kim Y. Avenell,Izzy Boyfield,Martyn C. Coldwell,Michael S. Hadley,(unknown),(unknown),Christopher N. Johnson,(unknown),Graham J. Riley,(unknown),Stephen A. Smith,(unknown),Geoffrey Stemp,Kevin M. Thewlis	6
16	SB 242084, a Selective and Brain Penetrant 5-HT 2C Receptor Antagonist 1997 ·Neuropharmacology ·G.A. Kennett,Martyn Wood,Fiona Bright,Brenda Trail,Graham J. Riley,Vicky Holland,Kim Y. Avenell,Tania O. Stean,N. Upton,Steven M. Bromidge,Ian T. Forbes,Arthur Brown,Derek N. Middlemiss,Thomas P. Blackburn	455
17	Synthesis and muscarinic activities of quinuclidin-3-yltriazole and -tetrazole derivatives 1992 ·Journal of Medicinal Chemistry ·Harry J. Wadsworth,S. M. Jenkins,Barry S. Orlek,Frederick Cassidy,Michael Clark,Frank Brown,Graham J. Riley,(unknown),Julie A. Hawkins,Christopher Naylor	68
18	Comparison of azabicyclic esters and oxadiazoles as ligands for the muscarinic receptor 1991 ·Journal of Medicinal Chemistry ·Barry S. Orlek,Frank E. Blaney,Frank Brown,Michael Clark,Michael S. Hadley,(unknown),Graham J. Riley,(unknown),Harry J. Wadsworth,Paul Wyman	171
19	The selective dopamine antagonist properties of BRL 34778: a novel substituted benzamide 1988 ·Psychopharmacology ·Frank Brown,William Campbell,Michael Clark,(unknown),Michael S. Hadley,(unknown),Philip B. Mitchell,(unknown),Graham J. Riley,James Semple	5
20	Effects of high temperature on the germination of maize (Zea mays L.) 1981 ·Planta ·Graham J. Riley	29

About Graham J. Riley

Graham J. Riley is a scholar working on Cellular and Molecular Neuroscience, Physiology and Organic Chemistry, having authored 70 papers that have together received 4.1k indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (35 papers), Neurotransmitter Receptor Influence on Behavior (20 papers) and Pharmacological Receptor Mechanisms and Effects (10 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (2.3k citations), Endocrine and Autonomic Systems (312 citations) and Pharmacology (779 citations). Graham J. Riley has collaborated with scholars based in United Kingdom, United States and Italy. Frequent co-authors include Steven M. Bromidge, Derek N. Middlemiss, Tania O. Stean, Ian T. Forbes, Vicky Holland, David R. Thomas, Jim J. Hagan, Martyn Wood, Gary Price and Neil Upton. Their work appears in journals such as The Lancet, Journal of Medicinal Chemistry and Journal of Neurochemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact